Your voice can help make metastatic breast cancer clinical trials more diverse.
become: Black Experience of Clinical Trials and Opportunities for Meaningful Engagement
The BECOME Survey is now closed. Thank you to all who participated. Sign up below to receive the survey findings.
The data tells a disturbing story. In the U.S., the mortality rate for non-Hispanic Black women with breast cancer is 40% higher than for non-Hispanic white women.1 And, while clinical trials help improve outcomes and survival, Black people represent only 3% to 6% of patients in all cancer clinical trials.2
How can we ensure Black people are better represented in cancer research? Finding the answer starts with patient voices.
Building on a 2019 project conducted by Marina Kaplan, an epidemiologist who lived with metastatic breast cancer, BECOME is a new research initiative designed to find solutions within the Black community. Using real-life patient input, BECOME looks for practical and actionable ways to make it easier for Black people living with MBC to take part in research trials. Your survey responses will help patients make more knowledgeable decisions, educate doctors on how to support patients in joining trials, and help researchers understand and design clinical trials in a way that encourages Black participation.
SEE The Survey FINDINGS
Join the MBC Alliance’s mailing list to get notified of the BECOME project findings when they are published, including actionable ways for healthcare providers and researchers to encourage Black participation in clinical trials.
Representation in research matters.
You can help.
“As a metastatic breast cancer patient, I don’t want my daughter to go through what I’ve experienced. I want to understand barriers to clinical trials for the Black community, so we can find answers on why Black men and women with MBC are dying at a faster rate.”
– Stephanie Walker, BECOME Project Lead
Black people are impacted by MBC at higher rates, but are rarely part of clinical research trials for new treatments.
about the project
In memoriam: Marina Pomare Kaplan, 1962-2020
In 2019, epidemiologist and patient advocate Marina Kaplan presented a poster at SABCS on increasing participation in clinical trials: patient-driven solutions. Only 8.87% of survey respondents were Black, reflecting the current rate of Black clinical trial participation of about 6.2%.
Today, patient advocate Stephanie Walker and a diverse project team are carrying on Marina’s desire to conduct deeper research in the Black community on barriers to clinical trial participation by partnering with MBCA to launch the BECOME project. This patient-focused initiative reflects our belief that what impacts one, impacts all.
COVID-19’s impact and the success of Black Lives Matter makes now the right time for collaborative solutions. BECOME will help our members better educate patients and clinicians, and impact clinical trial design and recruitment to increase participation and representation of Black patients with MBC.
The BECOME project was designed by research professionals, Alliance members, and patients living with MBC around the goal of listening first to patient voices – with input from scientists and oncologists – to find solutions for increasing Black participation in clinical trials. The work plan for the project includes:
A literature review of prior research papers that look at the barriers to Black patient participation in cancer clinical trials
In-depth interviews with Black patients and healthcare professionals on what they see as barriers to Black people participating in clinical trials
A survey of MBC patients that aims to better understand the numbers behind the Black community’s understanding of, or experience with, clinical trials.
A final report that summarizes the research results, and recommends key solutions that pharma and organizations can put into action to make it easier for Black people to participate in clinical trials
Planning for BECOME began in October 2020. In-depth interviews took place in Winter 2020-21. The patient survey was released in May 2021 and closed on July 31, 2021. Project findings are expected in Fall 2021.
Learn more about the preparatory research that paved the way for the BECOME project.
Support the Project
Are you a clinician, community leader or patient advocate who would like to support outreach efforts for the BECOME research initiative? Contact project lead Stephanie Walker to learn how to get involved in improving access and diversity in MBC clinical trials.